Free Trial

Curaleaf (OTCMKTS:CURLF) Shares Gap Down - What's Next?

Curaleaf logo with Medical background

Key Points

  • Curaleaf Holdings, Inc. shares gapped down to $2.83 at opening after closing at $3.03, with the stock currently trading at $2.93 and a trading volume of 158,395 shares.
  • Cormark upgraded Curaleaf from a "hold" to a "moderate buy" rating, contributing to an overall average rating of "Strong Buy" from analysts.
  • The company reported a quarterly EPS of ($0.06), surpassing predictions of ($0.07), although it maintains a negative return on equity of 14.61% and a net margin of 18.08%.
  • Interested in Curaleaf? Here are five stocks we like better.

Shares of Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report) gapped down prior to trading on Monday . The stock had previously closed at $3.03, but opened at $2.83. Curaleaf shares last traded at $2.93, with a volume of 158,395 shares trading hands.

Analysts Set New Price Targets

Separately, Cormark raised shares of Curaleaf from a "hold" rating to a "moderate buy" rating in a research report on Friday, August 8th. One research analyst has rated the stock with a Strong Buy rating, According to MarketBeat, the stock presently has an average rating of "Strong Buy".

Read Our Latest Analysis on CURLF

Curaleaf Stock Up 3.6%

The company has a market capitalization of $2.11 billion, a price-to-earnings ratio of -9.81 and a beta of 0.71. The company has a quick ratio of 0.70, a current ratio of 1.47 and a debt-to-equity ratio of 1.00. The firm has a 50 day moving average price of $2.58 and a two-hundred day moving average price of $1.49.

Curaleaf (OTCMKTS:CURLF - Get Free Report) last issued its quarterly earnings results on Wednesday, August 6th. The company reported ($0.06) EPS for the quarter, beating analysts' consensus estimates of ($0.07) by $0.01. Curaleaf had a negative return on equity of 14.61% and a negative net margin of 18.08%. As a group, sell-side analysts expect that Curaleaf Holdings, Inc. will post -0.25 earnings per share for the current year.

Curaleaf Company Profile

(Get Free Report)

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Curaleaf Right Now?

Before you consider Curaleaf, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.

While Curaleaf currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.